Source:http://linkedlifedata.com/resource/pubmed/id/21874508
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-10-3
|
pubmed:abstractText |
To evaluate roles of tumor-associated macrophages (TAMs) for prognosis of classical Hodgkin lymphoma (CHL). Expression of markers for TAMs, CD68, HLA-DR, CD163, HLA-DR/CD68 (M1), and CD163/CD68 (M2) was immunohistochemically examined in 82 cases with CHL. Positively stained cells were counted and correlation of number of TAMs and patients' survival time was analyzed. Number of CD163+ cells and M2 cells was significantly correlated with shorter overall survival (P?<?0.05), while it was marginally significant for CD68+ cells (P?=?0.0827). HLA-DR?+?cells and M1 cells showed no significant correlation with overall survival. When confined to mixed cellularity subtype, number of M1 cells was correlated with favorable prognosis (P?<?0.05), while M2 did not (P?=?0.7). Older age and male sex were unfavorable factors for prognosis. At multivariate analysis, number of CD163+ cells, M2+ cells, and age were independent factors for poor overall survival (P?=?0.03, 0.02, and 0.01, respectively). CD163+ cells and M2 cells might work to be tumor promotive in CHL. M1 cells might be tumor suppressive in mixed cellularity type.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1432-2307
|
pubmed:author |
pubmed-author:AozasaKatsuyukiK,
pubmed-author:HashimotoKojiK,
pubmed-author:IkedaJunichiroJ,
pubmed-author:MoriiEiichiE,
pubmed-author:ShibayamaHirohikoH,
pubmed-author:TakeHironoriH,
pubmed-author:TatsumiYoichiY,
pubmed-author:TsudoMitsuruM,
pubmed-author:TsukaguchiMachikoM,
pubmed-author:WadaNaokiN,
pubmed-author:YamagamiTamotsuT,
pubmed-author:ZakiMona A AMA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
459
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
361-6
|
pubmed:meshHeading |
pubmed-meshheading:21874508-Adolescent,
pubmed-meshheading:21874508-Adult,
pubmed-meshheading:21874508-Aged,
pubmed-meshheading:21874508-Aged, 80 and over,
pubmed-meshheading:21874508-Female,
pubmed-meshheading:21874508-Hodgkin Disease,
pubmed-meshheading:21874508-Humans,
pubmed-meshheading:21874508-Immunohistochemistry,
pubmed-meshheading:21874508-Kaplan-Meier Estimate,
pubmed-meshheading:21874508-Macrophages,
pubmed-meshheading:21874508-Male,
pubmed-meshheading:21874508-Middle Aged,
pubmed-meshheading:21874508-Prognosis,
pubmed-meshheading:21874508-Proportional Hazards Models,
pubmed-meshheading:21874508-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma.
|
pubmed:affiliation |
Department of Pathology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|